NCT01226953View on ClinicalTrials.gov

Immunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 365-569 Days Old Healthy Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

660

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

March 31, 2011

Conditions
Haemophilus Influenzae Type b (Hib) Infection
Interventions
BIOLOGICAL

Haemophilus influenzae type b (Hib) vaccine

Comparator study of two commercially available Haemophilus influenzae type b (Hib) vaccines

Trial Locations (1)

Unknown

Hebei Province

Sponsors

Lead Sponsor

Novartis Vaccines
All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY